HLA等位基因-KIR配对对南非HIV临床结局的影响
该研究在南非312例未治疗慢性HIV感染者中分析HLA-KIR配对对临床结局的影响。
要点
- HLA-C类型在KIR2DL3阳性者中显著影响病毒载量。
- HLA-C*16:01+KIR2DL3+与更高病毒载量和更低CD4+ T细胞计数相关。
- 该基因型者进展至AIDS更快,校正风险比1.9。
核心结论
- 特定HLA-KIR交互作用贡献于HIV免疫控制,HLA-C*16:01+KIR2DL3+与更差临床结局相关。
研究设计与样本
- 研究纳入南非312例未治疗慢性HIV感染成人,分析HLA-KIR配对对临床结局的影响。
临床怎么用
- HLA-C*16:01+KIR2DL3+基因型或可提示HIV疾病进展风险较高,但尚需验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: HLA class I contributes to HIV immune control through antigen presentation to cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells. In contrast to investigations of CTL, studies of NK cells in HIV control through HLA-killer immunoglobulin-like receptor (KIR) interactions remain sparse in African cohorts. METHODS: Treatment-naive, chronically HIV-infected adults (N = 312) were recruited from South Africa, and the effects of HLA-KIR pairs on clinical outcome were analyzed. RESULTS: There was no significant difference in viral load among all subjects with HLA alleles from the HLA-C1 group (P = .1). However, differences in HLA-C type significantly influenced viremia among 247 KIR2DL3 positives (P = .04), suggesting that specific HLA-KIR interactions contribute to immune control. Higher viral load (P = .02) and lower CD4+ T-cell counts (P = .008) were observed in subjects with HLA-C*16:01+KIR2DL3+. Longitudinal analysis showed more rapid progression to AIDS among HLA-C*16:01+KIR2DL3+ subjects (adjusted hazard ratio 1.9, P = .03) than those without this genotype, independent of CD4+ T-cell count and viral load. CONCLUSIONS: These results highlight the existence of unique anti-HIV innate immunity within distinct populations and the contribution of KIR on NK cells and some CTLs to the well-described HLA-mediated impact on HIV disease progression.
引用
- Mori M, Leitman E, Walker B, et al. Impact of HLA Allele-KIR Pairs on HIV Clinical Outcome in South Africa. J Infect Dis. 2019. PMID: 30520960. doi:10.1093/infdis/jiy692
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。